Lin BioScience, Inc. (TPEX:6696)
Taiwan · Delayed Price · Currency is TWD 162.50
+10.00 (6.56%)
Sep 5, 2025, 1:33 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 13.65 billion as of September 5, 2025. Its market cap has increased by 84.87% in one year.
Market Cap
13.65B
Enterprise Value
10.96B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
162.50
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 13.65B, an increase of 368.08%. That is a compound annual growth rate of 25.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 13.65B | 26.25% |
| Dec 31, 2024 | 10.81B | 20.85% |
| Dec 29, 2023 | 8.95B | -28.90% |
| Dec 30, 2022 | 12.58B | -1.94% |
| Dec 30, 2021 | 12.83B | 83.66% |
| Dec 31, 2020 | 6.99B | 284.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 394.73B |
| PharmaEssentia | 171.63B |
| Bora Pharmaceuticals Co., LTD. | 91.84B |
| Lotus Pharmaceutical | 50.76B |
| Lumosa Therapeutics | 40.43B |
| Oneness Biotech | 36.35B |
| Center Laboratories | 29.56B |
| Polaris Group | 29.31B |